|
Volumn 11, Issue 4 Suppl, 2005, Pages
|
The role of pharmacoeconomic modeling in evidence-based and value-based formulary guidelines.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
DECISION MAKING;
EVIDENCE BASED MEDICINE;
HUMAN;
PHARMACOECONOMICS;
PUBLICATION;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
COST-BENEFIT ANALYSIS;
DECISION MAKING;
ECONOMICS, PHARMACEUTICAL;
EVIDENCE-BASED MEDICINE;
FORMULARIES;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 22144492658
PISSN: 10834087
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (13)
|
References (11)
|